Effect of BL-5111-A, prazosin and phentolamine on responses of canine cutaneous veins to adrenergic activation.
D000818:Animals; D003042:Cocaine / Q000037:antagonists & inhibitors; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004336:Drug Antagonism; D004958:Estradiol; D004965:Estrogen Antagonists; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000502:physiology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010646:Phentolamine / Q000494:pharmacology*; D011224:Prazosin / Q000031:analogs & derivatives / Q000494:pharmacology*; D011433:Propranolol / Q000037:antagonists & inhibitors; D011799:Quinazolines / Q000494:pharmacology*; D012501:Saphenous Vein / Q000502:physiology; D013566:Sympathomimetics / Q000037:antagonists & inhibitors*
D004965:Estrogen Antagonists; D011799:Quinazolines; D013566:Sympathomimetics; D004958:Estradiol; D011433:Propranolol; C019578:tiodazosin; D003042:Cocaine; D009638:Norepinephrine; D011224:Prazosin; D010646:Phentolamine